Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rusfertide in Japanese Patients With Polycythemia Vera
NCT07648030Phase 2Recruiting
- Sponsor
- Takeda
- Start
- Jul 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of rusfertide in polycythemia vera (PV), sponsored by Takeda. Started Jul 2026; status: recruiting.
02
Drugs
rusfertide
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT07648030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648030.